NASDAQ:ANPC
Delisted
AnPac Bio-Medical Science Co., Ltd. Stock News
$4.37
+0 (+0%)
At Close: Aug 18, 2023
AnPac Bio 2021 First Half Revenue Up 128.5% with Non-GAAP Loss Reduced by 18.3%
07:30am, Friday, 01'st Oct 2021
PHILADELPHIA, Oct. 01, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China an
AnPac Bio Receives NASDAQ Notification Regarding Minimum Market Value of Listed Securities Deficiency
04:05pm, Thursday, 30'th Sep 2021
PHILADELPHIA, Sept. 30, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in the Uni
BioMedNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces Ownership Increase In Subsidiary Holding
12:19pm, Tuesday, 07'th Sep 2021
AnPac Bio-Medical Science (NASDAQ: ANPC) subsidiary AnPac Bio-Medical Science (Lishui) Co. Ltd. has increased its holding in AnPai (Shanghai) Healthcare Management Consultant Co. Ltd.
AnPac Bio Increases Ownership Percentage of its Subsidiary AnPai Healthcare from 20% to 60%
04:15pm, Friday, 03'rd Sep 2021
PHILADELPHIA, Sept. 03, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in the Uni
AnPac Bio's USA Laboratory Receives Accreditation from the College of American Pathologists
07:30am, Monday, 30'th Aug 2021
PHILADELPHIA, Aug. 30, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in the Unit
PHILADELPHIA, Aug. 23, 2021 (GLOBE NEWSWIRE) -- via Investor Wire – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with
AnPac Bio Taps Life Sciences and Diagnostics Veteran as US CEO
07:30am, Tuesday, 17'th Aug 2021
PHILADELPHIA, Aug. 17, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with op
AnPac Bio Announces Appointment of New Independent Director
07:30am, Friday, 23'rd Jul 2021
Independent Director has Strong Track Record at US Fortune 500 Companies Independent Director has Strong Track Record at US Fortune 500 Companies
AnPac Bio Began Generating Contract Medical Device R&D Revenue
06:30am, Wednesday, 21'st Jul 2021
Also in Final Stages of Partnership/Cooperation Discussions with Major Corporations Also in Final Stages of Partnership/Cooperation Discussions with Major Corporations
AnPac Bio Stock Gains On Robust Growth In Commercial Testing Volume In Q2
07:13am, Tuesday, 20'th Jul 2021
AnPac Bio-Medical Science Co Ltd (NASDAQ: ANPC) has announced strong growth in test volume in 1H of 2021. The total number of paid customers and testing volume increased almost 110% compared with 1H
PHILADELPHIA, July 20, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China an
AnPac Bio-Medical Stock Moves Higher On First Disease Treatment US Patent
09:22am, Friday, 18'th Jun 2021
AnPac Bio-Medical Science Co Ltd (NASDAQ: ANPC) has received its first disease treatment patent by the United States Patent and Trademark Office. The patent covers novel medical devices for both di
Best Biotech Penny Stocks to Buy Next Month? 3 For Your Watchlist
08:52am, Friday, 18'th Jun 2021
Are these biotech penny stocks to watch on your list for July 2021? The post Best Biotech Penny Stocks to Buy Next Month?
ANPC Stock Price Increases Over 20% Pre-Market: Why It Happened
08:16am, Friday, 18'th Jun 2021
The stock price of AnPac Bio-Medical Science Co Ltd (NASDAQ: ANPC) increased by over 20% pre-market. This is why it happened.
AnPac Bio's First Disease Treatment Patent Granted, and Its Cancer Treatment Project Secured Multi-Million Dollar Funds
06:30am, Friday, 18'th Jun 2021
PHILADELPHIA, June 18, 2021 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China an